Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma
Clinical trial NCT07276737 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07276737
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2029-12-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.